Abstract
Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.
| Original language | English |
|---|---|
| Pages (from-to) | 15-20+25 |
| Journal | Cardiovascular Reviews and Reports |
| Volume | 13 |
| Issue number | 11 |
| State | Published - 1992 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations. / Hilleman, Daniel E.; Nair, C. K.
In: Cardiovascular Reviews and Reports, Vol. 13, No. 11, 1992, p. 15-20+25.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic/pharmacodynamic considerations
AU - Hilleman, Daniel E.
AU - Nair, C. K.
PY - 1992
Y1 - 1992
N2 - Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.
AB - Advancing age is associated with important changes in the absorption, distribution, metabolism, and elimination of cardiovascular drugs. In this issue, Drs. Hilleman and Nair discuss cardiovascular drug therapy in the elderly, with special emphasis on pharmacokinetic and pharmacodynamic considerations. Following this, Dr. Rich reviews three recent articles on the use of angiotensin-converting-enzyme inhibitors in patients at risk for developing congestive heart failure, and another article on the exclusion of elderly subjects and women from clinical trials of pharmacologic interventions in acute myocardial infarction. Also included in this issue are a comprehensive annotated bibliography of the recent literature relevant to cardiovascular disease in the elderly, a report from the Council on Geriatric Cardiology summarizing recent research activities of the Council, and a calendar of upcoming meetings and events.
UR - http://www.scopus.com/inward/record.url?scp=0026446286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026446286&partnerID=8YFLogxK
M3 - Review article
VL - 13
SP - 15-20+25
JO - Cardiovascular Reviews and Reports
JF - Cardiovascular Reviews and Reports
SN - 0197-3118
IS - 11
ER -